By Pharmaceutical Commerce Staff

Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.

Cellular and genetic therapies drive a ‘new paradigm’ for logistics

Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging